Merck & Co Inc [MRK] stock is trading at $103.55, up 2.15%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MRK shares have gain 0.42% over the last week, with a monthly amount glided 1.87%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on December 04, 2024, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $130 for it. On November 11, 2024, downgrade downgraded it’s rating to Neutral. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $115 on October 17, 2024. Societe Generale downgraded its rating to a Sell but $104 remained the price target by the analyst firm on March 11, 2024. TD Cowen upgraded its rating to Outperform for this stock on January 04, 2024, and upped its price target to $135. In a note dated November 09, 2023, Deutsche Bank initiated an Buy rating and provided a target price of $115 on this stock.
Merck & Co Inc [MRK] stock has fluctuated between $94.48 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $136.43 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $103.55 at the most recent close of the market. An investor can expect a potential return of 31.75% based on the average MRK price forecast.
Analyzing the MRK fundamentals
Merck & Co Inc [NYSE:MRK] reported sales of 62.89B for the trailing twelve months, which represents a growth of 4.42%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.29 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 101.89 points at the first support level, and at 100.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 104.68, and for the 2nd resistance point, it is at 105.80.
Ratios To Look Out For
For context, Merck & Co Inc’s Current Ratio is 1.36. In addition, the Quick Ratio stands at 1.15 and the Cash Ratio stands at 0.49. Considering the valuation of this stock, the price to sales ratio is 4.16, the price to book ratio is 5.89 and price to earnings (TTM) ratio is 21.69.
Transactions by insiders
Recent insider trading involved Merck & Co., Inc., 10% Owner, that happened on Mar 11 ’24 when 21.4 million shares were purchased. EVP & CFO, Litchfield Caroline completed a deal on Feb 14 ’24 to sell 38291.0 shares. Meanwhile, Chairman, CEO & President Davis Robert M sold 0.15 million shares on Feb 13 ’24.
